These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8630629)

  • 1. Introduction: mechanism of action of NSAIDs.
    Vane JR
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():1-3. PubMed ID: 8630629
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology and clinical action of COX-2 selective NSAIDs.
    Bovill JG
    Adv Exp Med Biol; 2003; 523():201-14. PubMed ID: 15088852
    [No Abstract]   [Full Text] [Related]  

  • 3. Prime suspect.
    Manuel J
    Environ Health Perspect; 1997 Jan; 105(1):28-9. PubMed ID: 9074875
    [No Abstract]   [Full Text] [Related]  

  • 4. COX-2 inhibitors: a review.
    Houston AM; Teach SJ
    Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
    [No Abstract]   [Full Text] [Related]  

  • 5. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin and other anti-inflammatory drugs.
    Vane SJ
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S3-9. PubMed ID: 10992545
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cyclooxygenases in the spinal cord and the relationship with pain].
    Li SQ; Li WB
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.
    Pairet M; Engelhardt G
    Fundam Clin Pharmacol; 1996; 10(1):1-17. PubMed ID: 8900495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin endoperoxide H synthases-1 and -2.
    Smith WL; Dewitt DL
    Adv Immunol; 1996; 62():167-215. PubMed ID: 8781269
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of COX2 inhibitors.
    Flower RJ
    Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
    Steinhilber D
    Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
    [No Abstract]   [Full Text] [Related]  

  • 12. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 13. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 14. [COX-2 expression in gastric cancers].
    Sakamoto C
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of action of anti-inflammatory drugs.
    Vane JR
    Ernst Schering Res Found Workshop; 2000; (31):1-23. PubMed ID: 10943325
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction. The role of COX-2-specific inhibitors in clinical practice.
    Lipsky PE
    Am J Med; 2001 Feb; 110 Suppl 3A():1S-2S. PubMed ID: 11173042
    [No Abstract]   [Full Text] [Related]  

  • 17. The new NSAIDs: cox-2 inhibitors.
    Capriotti T
    Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action.
    Morham SG; Langenbach R; Mahler J; Smithies O
    Adv Exp Med Biol; 1997; 407():131-8. PubMed ID: 9321943
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of action of anti-inflammatory drugs.
    Vane JR; Botting RM
    Adv Exp Med Biol; 1997; 433():131-8. PubMed ID: 9561120
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
    Chan CC; Rodger IW
    Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.